EUVIMEDEUVIMED entdecken
Crossref

Tumor-Tropic Bacterial–Nanoparticle Hybrids for Metabolic Reprogramming and Cancer Immunotherapy

Ping Ji, Chujie Lin, Jiaxin Wang, Chongzhou Fang, Minghua Li, Yuanchao Shi, Ya Zhong, Feng Wang, Hai-Yan Xie iD, Yongsheng Zhao iD, Jing Mu iD

ACS Nano · 16.06.2026 · 20 (23) · 16828-16843

DOI: 10.1021/acsnano.6c02876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.06.2026. Verfasst von Ping Ji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Me…. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Shewanella, Doxorubicin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Medical Research Fund, Shenzhen Science and Technology Innovation Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNanoparticlesShewanellaDoxorubicinNeoplasmsAnimalsMetabolic ReprogrammingMiceHumansTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

bacteria-mediated deliverybiohybrid systemcancer immunotherapymetabolic reprogrammingtumor microenvironment reprogramming

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.
  • Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
  • Central Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Chemical Biology Center, Peking University, Beijing 100191, China.

ORCID-Profile: Hai-Yan Xie, Yongsheng Zhao, Jing Mu

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Medical Research Fund
  • Shenzhen Science and Technology Innovation Commission
  • Sanming Project of Medicine in Shenzhen
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Ji, P., Lin, C., Wang, J., Fang, C., Li, M., Shi, Y., Zhong, Y., Wang, F., Xie, H. Y., Zhao, Y., & Mu, J. (2026). Tumor-Tropic Bacterial–Nanoparticle Hybrids for Metabolic Reprogramming and Cancer Immunotherapy. ACS Nano, 20(23), 16828-16843. https://doi.org/10.1021/acsnano.6c02876

Vancouver

Ji P, Lin C, Wang J, Fang C, Li M, Shi Y, et al. Tumor-Tropic Bacterial–Nanoparticle Hybrids for Metabolic Reprogramming and Cancer Immunotherapy. ACS Nano. 2026;20(23):16828-16843. doi:10.1021/acsnano.6c02876

BibTeX
@article{Ji2026,
  author = {Ji, Ping and Lin, Chujie and Wang, Jiaxin and Fang, Chongzhou and Li, Minghua and Shi, Yuanchao and Zhong, Ya and Wang, Feng and Xie, Hai-Yan and Zhao, Yongsheng and Mu, Jing},
  title = {Tumor-Tropic Bacterial–Nanoparticle Hybrids for Metabolic Reprogramming and Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {23},
  pages = {16828--16843},
  doi = {10.1021/acsnano.6c02876}
}
Kostenlos starten →